Cargando…
Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature
BACKGROUND: Circulating levels of chemerin are significantly higher in hypertensive patients and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 (CMKLR1 or ChemR23) and is proposed to activate the “orphan” G‐protein‐coupled receptor 1 (GPR1), which has been lin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121526/ https://www.ncbi.nlm.nih.gov/pubmed/27742615 http://dx.doi.org/10.1161/JAHA.116.004421 |
_version_ | 1782469425238114304 |
---|---|
author | Kennedy, Amanda J. Yang, Peiran Read, Cai Kuc, Rhoda E. Yang, Lucy Taylor, Emily J. A. Taylor, Colin W. Maguire, Janet J. Davenport, Anthony P. |
author_facet | Kennedy, Amanda J. Yang, Peiran Read, Cai Kuc, Rhoda E. Yang, Lucy Taylor, Emily J. A. Taylor, Colin W. Maguire, Janet J. Davenport, Anthony P. |
author_sort | Kennedy, Amanda J. |
collection | PubMed |
description | BACKGROUND: Circulating levels of chemerin are significantly higher in hypertensive patients and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 (CMKLR1 or ChemR23) and is proposed to activate the “orphan” G‐protein‐coupled receptor 1 (GPR1), which has been linked with hypertension. Our aim was to localize chemerin, CMKLR1, and GPR1 in the human vasculature and determine whether 1 or both of these receptors mediate vasoconstriction. METHODS AND RESULTS: Using immunohistochemistry and molecular biology in conduit arteries and veins and resistance vessels, we localized chemerin to endothelium, smooth muscle, and adventitia and found that CMKLR1 and GPR1 were widely expressed in smooth muscle. C9 (chemerin149–157) contracted human saphenous vein (pD (2)=7.30±0.31) and resistance arteries (pD (2)=7.05±0.54) and increased blood pressure in rats by 9.1±1.0 mm Hg at 200 nmol. Crucially, these in vitro and in vivo vascular actions were blocked by CCX832, which we confirmed to be highly selective for CMKLR1 over GPR1. C9 inhibited cAMP accumulation in human aortic smooth muscle cells and preconstricted rat aorta, consistent with the observed vasoconstrictor action. Downstream signaling was explored further and, compared to chemerin, C9 showed a bias factor=≈5000 for the G(i) protein pathway, suggesting that CMKLR1 exhibits biased agonism. CONCLUSIONS: Our data suggest that chemerin acts at CMKLR1, but not GPR1, to increase blood pressure. Chemerin has an established detrimental role in metabolic syndrome, and these direct vascular actions may contribute to hypertension, an additional risk factor for cardiovascular disease. This study provides proof of principle for the therapeutic potential of selective CMKLR1 antagonists. |
format | Online Article Text |
id | pubmed-5121526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51215262016-12-06 Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature Kennedy, Amanda J. Yang, Peiran Read, Cai Kuc, Rhoda E. Yang, Lucy Taylor, Emily J. A. Taylor, Colin W. Maguire, Janet J. Davenport, Anthony P. J Am Heart Assoc Original Research BACKGROUND: Circulating levels of chemerin are significantly higher in hypertensive patients and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 (CMKLR1 or ChemR23) and is proposed to activate the “orphan” G‐protein‐coupled receptor 1 (GPR1), which has been linked with hypertension. Our aim was to localize chemerin, CMKLR1, and GPR1 in the human vasculature and determine whether 1 or both of these receptors mediate vasoconstriction. METHODS AND RESULTS: Using immunohistochemistry and molecular biology in conduit arteries and veins and resistance vessels, we localized chemerin to endothelium, smooth muscle, and adventitia and found that CMKLR1 and GPR1 were widely expressed in smooth muscle. C9 (chemerin149–157) contracted human saphenous vein (pD (2)=7.30±0.31) and resistance arteries (pD (2)=7.05±0.54) and increased blood pressure in rats by 9.1±1.0 mm Hg at 200 nmol. Crucially, these in vitro and in vivo vascular actions were blocked by CCX832, which we confirmed to be highly selective for CMKLR1 over GPR1. C9 inhibited cAMP accumulation in human aortic smooth muscle cells and preconstricted rat aorta, consistent with the observed vasoconstrictor action. Downstream signaling was explored further and, compared to chemerin, C9 showed a bias factor=≈5000 for the G(i) protein pathway, suggesting that CMKLR1 exhibits biased agonism. CONCLUSIONS: Our data suggest that chemerin acts at CMKLR1, but not GPR1, to increase blood pressure. Chemerin has an established detrimental role in metabolic syndrome, and these direct vascular actions may contribute to hypertension, an additional risk factor for cardiovascular disease. This study provides proof of principle for the therapeutic potential of selective CMKLR1 antagonists. John Wiley and Sons Inc. 2016-10-14 /pmc/articles/PMC5121526/ /pubmed/27742615 http://dx.doi.org/10.1161/JAHA.116.004421 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Kennedy, Amanda J. Yang, Peiran Read, Cai Kuc, Rhoda E. Yang, Lucy Taylor, Emily J. A. Taylor, Colin W. Maguire, Janet J. Davenport, Anthony P. Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature |
title | Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature |
title_full | Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature |
title_fullStr | Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature |
title_full_unstemmed | Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature |
title_short | Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature |
title_sort | chemerin elicits potent constrictor actions via chemokine‐like receptor 1 (cmklr1), not g‐protein‐coupled receptor 1 (gpr1), in human and rat vasculature |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121526/ https://www.ncbi.nlm.nih.gov/pubmed/27742615 http://dx.doi.org/10.1161/JAHA.116.004421 |
work_keys_str_mv | AT kennedyamandaj chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT yangpeiran chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT readcai chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT kucrhodae chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT yanglucy chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT tayloremilyja chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT taylorcolinw chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT maguirejanetj chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature AT davenportanthonyp chemerinelicitspotentconstrictoractionsviachemokinelikereceptor1cmklr1notgproteincoupledreceptor1gpr1inhumanandratvasculature |